Longitudinal Observation of Treatment Patterns and Outcomes for Patients with Fibromyalgia: 12-Month Findings from the REFLECTIONS Study
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To describe 12-month treatment patterns and outcomes for patients starting a new medication for fibromyalgia in routine clinical practice. DESIGN AND OUTCOME MEASURES: Data from 1,700 patients were collected at baseline and 1, 3, 6, and 12 months. Repeated measures and Poisson regression models controlling for demographic, clinical, and baseline outcomes were used to assess changes in health outcomes (Brief Pain Inventory severity and interference, Sheehan Disability Scale, Fibromyalgia Impact Questionnaire), satisfaction, and economic factors for patients who initiated on pregabalin (214, 12.6%), duloxetine (264, 15.5%), milnacipran (134, 7.9%), or tricyclic antidepressants (66, 3.9%). Sensitivity analyses were run using propensity-matched cohorts. RESULTS: Patients started on 145 unique drugs for fibromyalgia, and over 75% of patients took two or more medications concurrently for fibromyalgia at each time point assessed. Overall, patients showed improvement on the four health outcomes, with few differences across medication cohorts. At baseline, patients reported annual averages of 20.3 visits for outpatient care, 27.7 missed days of work, and 32.6 days of care by an unpaid caregiver. The duloxetine and milnacipran (vs pregabalin or tricyclic antidepressant) cohorts had fewer outpatient visits during the 12-month study. Patients reported satisfaction with overall treatment and their fibromyalgia medication (46.0% and 42.8%, respectively). CONCLUSIONS: In this real-world setting, patients with fibromyalgia reported modest improvements, high resource, and medication use, and were satisfied with the care they received. Cohort differences were difficult to discern because of the high rates of drug discontinuation and concomitant medication use over the 12-month study period.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Self-citationHainmueller, J. (2012) · Political Analysis · doi:10.1093/pan/mpr025 · Cited by 6,026
Medication compliance and persistence: terminology and definitions
Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
An internet survey of 2,596 people with fibromyalgia
Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-8-27 · Cited by 865
Gender differences in the reporting of physical and somatoform symptoms
Kroenke, K., & Spitzer, R. L. (1998) · Psychosomatic Medicine · doi:10.1097/00006842-199803000-00006 · Cited by 559
Self-citationGuidelines on the management of fibromyalgia syndrome – A systematic review
Häuser, W., Thieme, K., & Turk, D. C. (2010) · European Journal of Pain · doi:10.1016/j.ejpain.2009.01.006 · Cited by 347
Fava, M., Graves, L. M., Benazzi, F., Scalia, M. J., Iosifescu, D. V., Alpert, J. E., & Papakostas, G. I. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1113 · Cited by 229
Employees With Fibromyalgia: Medical Comorbidity, Healthcare Costs, and Work Loss
White, L. A., Birnbaum, H. G., Kaltenboeck, A., Tang, J., Mallett, D., & Robinson, R. L. (2008) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e31815cff4b · Cited by 168
Self-citationAssessment of Patients with Fibromyalgia Syndrome
Mease, P. J. (2008) · Journal of Musculoskeletal Pain · doi:10.1080/10582450801960347 · Cited by 20
Self-citation
Cited by
Long-Term Outcomes of Adolescents With Juvenile-Onset Fibromyalgia in Early Adulthood
Kashikar-Zuck, S., Cunningham, N., Sil, S., Bromberg, M. H., Lynch-Jordan, A. M., Strotman, D., Peugh, J., Noll, J., Ting, T. V., Powers, S. W., et al. (2014) · Pediatrics · doi:10.1542/peds.2013-2220 · Cited by 135
Arout, C. A., Sofuoglu, M., Bastian, L. A., & Rosenheck, R. A. (2018) · Journal of Women s Health · doi:10.1089/jwh.2017.6622 · Cited by 122
Walitt, B., Katz, R. S., Bergman, M. J., & Wolfe, F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157235 · Cited by 97
Luciano, J. V., Barrada, J. R., Aguado, J., Osma, J., & García-Campayo, J. (2014) · Psychological Assessment · doi:10.1037/a0035284 · Cited by 62
Luciano, J. V., D’Amico, F., Cerdà-Lafont, M., Peñarrubia-María, M. T., Knapp, M., Cuesta-Vargas, A. I., Serrano-Blanco, A., & García-Campayo, J. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0451-y · Cited by 48
“One such study is REFLECTIONS (Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments) [49], a prospective 12-month observational study of adult patients with fibromyalgia (N = 1,700) who started a new pharmacologic treatment among four medication cohorts (pregabalin, duloxetine, milna…”
Background
Metadata
- Authors
- Robinson, R. L., Kroenke, K., Williams, D. A., Mease, P., Chen, Y., Faries, D., Peng, X., Hann, D., Wohlreich, M., & McCarberg, B.
- Venue
- Pain Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-09
- Volume
- 14
- Issue
- 9
- Pages
- 1400-1415
- ISSN
- 1526-2375 (ISSN-L)
- 1526-4637
- OpenAlex
- W2153024655
- Cited by
- 45
- References
- 10
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.